Search

everythinglearnresearchcommunity

for

Search:↓

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

People with alopecia areata often have lower vitamin D levels than healthy people.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Too much epidermal growth factor can cause hair loss.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Alefacept does not effectively treat severe alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Baricitinib is the most effective treatment for alopecia areata.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Better documentation of alopecia areata in Black individuals is needed to improve diagnosis.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.